Figure 4.
DAMP (HMGB1) levels of participants (CD24Fc multidose, n = 12) in the open-label expansion cohort. Plasma samples obtained on day –7 (±2 days, preconditioning), day –1 (postconditioning, pretreatment), and day 28 (±2 days, post-HSCT, posttreatment). ∗P < .05; Wilcoxon signed-rank test (GraphPad Prism 8.0). SE, standard error.

DAMP (HMGB1) levels of participants (CD24Fc multidose, n = 12) in the open-label expansion cohort. Plasma samples obtained on day –7 (±2 days, preconditioning), day –1 (postconditioning, pretreatment), and day 28 (±2 days, post-HSCT, posttreatment). ∗P < .05; Wilcoxon signed-rank test (GraphPad Prism 8.0). SE, standard error.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal